Author

Kim Klein

University Medical Center UtrechtORCID 0000-0002-9794-1071Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

Anja Krippner‐HeidenreichiD· 1 shared Annelisa M. CorneliD· 1 shared Ester Dünnebach· 1 shared Farnaz BarnehiD· 1 shared Gertjan J.L. KaspersiD· 1 shared Jacqueline J CloosiD· 1 shared Joost B. KoedijkiD· 1 shared Jurgen H. E. KuballiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anja Krippner‐HeidenreichORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia

Farnaz Barneh, Joost B. Koedijk, Noa Esther Wijnen, Tom Meulendijks, Minoo Ashtiani, Ester Dünnebach, Noël M M Dautzenberg, Annelisa M. Cornel, Anja Krippner‐Heidenreich, Kim Klein, Michel C. Zwaan, Jurgen H. E. Kuball, Stefan Nierkens, Jacqueline J Cloos, Gertjan J.L. Kaspers, Olaf T Heidenreich

This study evaluates CD19 expression in pediatric AML and shows that CD19-directed immunotherapies are effective against CD19+ AML, similar to their efficacy in BCP-ALL.

Haematologica · Aug 8, 2024Peer-reviewedImmunology